Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
910
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
-1.06M
-
Total reported value, excl. options
-
$23.8B
-
Value change
-
-$257M
-
Put/Call ratio
-
1.73
-
Number of buys
-
461
-
Number of sells
-
-393
-
Price
-
$258.00
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2025
1,028 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2025.
RESMED INC - Common Stock (RMD) has 910 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
of 146M outstanding shares and own 62.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.7M shares), BlackRock, Inc. (12.4M shares), STATE STREET CORP (6.62M shares), Bank of New York Mellon Corp (5.05M shares), GEODE CAPITAL MANAGEMENT, LLC (4.22M shares), MORGAN STANLEY (2.66M shares), Invesco Ltd. (2.18M shares), NORTHERN TRUST CORP (1.72M shares), NORGES BANK (1.19M shares), and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (1.04M shares).
This table shows the top 910 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.